Companies/DIH Holding US, Inc.

Company profile

DIH Holding US, Inc.

OTC: DHAI · Healthcare · Medical - Devices

PublicHQ Norwell, MACIK 0001883788Reports USD

#403 of 1,394 Healthcare companies by revenue37th-percentile growth

EA Score

——

FH —DQ 4GM —SS 32

v0.1 · 25/100 weight · pillars only

↑ workforce scale, net margin · ↓ filing timeliness, listing tenure

Methodology →

Revenue TTM

$62.9M

Rev growth YoY (TTM)

-4.2%

Net income (FY)

-$8.7M

Employees

178

Market cap

$41.9k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$62.9M$62.9M2025

Net income-$8.7M-$8.7M2025

Operating income-$7.0M-$7.0M2025

Total assets$26.8M$26.8M2025

Liabilities$63.9M$63.9M2025

Equity-$37.1M-$37.1M2025

Revenue trend

FY2024 – FY2025 · USD

$54.1M

FY24

$64.5M

FY24

$62.9M

FY25

Revenue by segment

Filed disclosures · FY2025

By product

Devices79%

Service19%

Other2%

By geography

EMEA58%

Americas27%

Asia Pacific15%

The read

DIH Holding US, Inc. booked $62.9M in FY2025 revenue, contracting 2.5% year over year — slower than 63% of Healthcare companies we track, at a -13.8% net margin.

Peers · Healthcare

Health Discovery Corporation——BioTech Medics, Inc.——Hemagen Diagnostics, Inc.——Nunzia Pharmaceutical Company——

Key facts

CEOLynden Bass

SectorHealthcare

IndustryMedical - Devices

HeadquartersNorwell, MA

ExchangeOTC: DHAI

Employees178

IPO date2024-02-14

Latest filings

8-K2025-12-18 8-K2025-11-28 8-K2025-11-06 8-K2025-10-21 8-K2025-10-20 10-K2025-10-20 8-K2025-10-17 8-K2025-10-08

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.